Antifungal activity study of the monoterpene thymol against Cryptococcus neoformans

References

• Barnett JA. 2010. A history of research on yeasts 14: medical yeasts part 2, Cryptococcus neoformans. Yeast. 27(11):875–904.
   PubMed Web of Science ®Google Scholar
• Belato KK, Oliveira JR, Oliveira FS, Oliveira LD, Camargo SEA. 2018. Cytotoxicity and genotoxicity of thymol verified in murine macrophages (RAW 264.7) after antimicrobial analysis in Candida albicans, Staphylococcus aureus, and Streptococcus mutans. J Functional Foods. 40:455–460.
   Web of Science ®Google Scholar
• Cantón, E, Pemán, J, Viudes A, Quindós G, Gobernado M, Espinel-Ingroff A. 2003. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis. 45(3):203–206.
   PubMed Web of Science ®Google Scholar
• Carraro TCMM, Khalil NM, Mainardes RM. 2014. Amphotericin B-loaded polymeric nanoparticles: Formulation optimization by factorial design. Pharm Devel Technol. 21(2):140–146.
   PubMed Web of Science ®Google Scholar
• Chastain DB, Henao-Martínez AF, Franco-Paredes C. 2017. Opportunistic invasive mycoses in AIDS: Cryptococcosis, histoplasmosis, coccidiodomycosis, and talaromycosis. Curr Infect Dis Rep. 19(10):36.
   PubMed Web of Science ®Google Scholar
• Cleeland R, Squires E. 1991. Evaluation of new antimicrobials in vitro and in experimental animal infections Antibiotics Lab Med. 3:739–787.
   Google Scholar
• CLSI. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved. National Committee for Clinical Laboratory Standards, M 27-A2. 22(15).
   Google Scholar
• Cuenca-Estrella M. 2010. Antifúngicos en el tratamiento de las infecciones sistémicas: Importancia del mecanismo de acción, espectro de actividad y resistencias. Rev Esp Quimioter. 23(4):169–176.
   PubMed Web of Science ®Google Scholar
• Dantas BT, Ferreira SB, Pinheiro LS, Menezes CPD, Guerra FQS, Sousa JPD, Lima EDO. 2015. Antifungal Activity of Phytochemicals against Samples of Penicillium. Int J Trop Dis Health. 10:1–9.
   Google Scholar
• Denning DW, Hope WW. 2010. Therapy for fungal diseases: Opportunities and priorities. Trends Microbiol. 18(5):195–204.
   PubMed Web of Science ®Google Scholar
• El-Fane M, Badaoui L, Ouladlahsen A, Sodqi M, Marih L, Chakib A, Marhoum KEF. 2015. Cryptococcosis during HIV infection. J Mycol Médicale. 25(4):257–262.
   PubMed Web of Science ®Google Scholar
• Eloff JN. 1998. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Medica. 64(8):711–713.
   PubMed Web of Science ®Google Scholar
• Emiroglu ZK, Yemiş GP, Coşkun BK, Candogan K. 2010. Antimicrobial activity of soy edible films incorporated with thyme and oregano essential oils on fresh ground beef patties. Meat Sci. 86(2):283–288.
   PubMed Web of Science ®Google Scholar
• Ernst EJ, Klepser ME, Ernst ME, Messer SA, Pfaller MA. 1999. In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. Diagn Microbiol Infect Dis. 33(2):75–80.
   PubMed Web of Science ®Google Scholar
• Ernst ME, Klepser ME, Wolfe EJ, Pfaller MA. 1996. Antifungal dynamics of LY 303366, an investigational echinocandin B analog against Candida spp. Diagn Microbiol Infect Dis. 26:125–131.
   PubMed Web of Science ®Google Scholar
• Escalante A, Gattuso M, Pérez P, Zacchino, S. 2008. Evidence of the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J Natural Prod. 71(10):1720–1725.
   PubMed Web of Science ®Google Scholar
• Huang W, Zhang Z, Han X, Tang J, Wang J, Dong S, Wang E. 2002. Ion channel behavior of Anfotericin B in sterol-free and cholesterol or ergosterol containing supported Phosohatidylcholine Bilayes Model membranes investigated by Eletrochemistry and Spectroscopy. Biophys J. 83:3245–3255.
   PubMed Web of Science ®Google Scholar
• Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. 1998. Influence of test conditions on antifungal time-kill curve results: proposal of standardized methods. Antimicrob Agents Chemother. 42(5):1207–1212.
   PubMed Web of Science ®Google Scholar
• Lima DSD, Lima JC, Cavalcanti RMCB, Santos BHCD, Lima IO. 2017. Study of the antibacterial activity of thymol and carvacrol monoterpenes against strains of Escherichia coli producing extended-spectrum β-lactamases. Revista Pan-Amazônica de Saúde, 8(1):17–21.
   Google Scholar
• Lima IO, Pereira FDO, Oliveira WAD, Lima EDO, Menezes EA, Cunha FA, Diniz MDFFM. 2013. Antifungal activity and mode of action of carvacrol against Candida albicans strains. J Essen Oil Res. 25(2):138–142.
   Web of Science ®Google Scholar
• Lindenberg ASC, Chang MR, Paniago AMM, Lazéra MDS, Moncada PMF, Bonfim GF, Nogueira SA, Wanke B. Clinical and epidemiological features of 123 cases of cryptococcosis in Mato Grosso do Sul, Brazil. Revista do Instituto de Medicina Tropical de São Paulo. 50(2):75–78.
   PubMed Web of Science ®Google Scholar
• Mota KSL, Pereira FO, Oliveira WA, Lima IO, Lima EO. 2012. Antifungal activity of Thymus vulgaris L. Essential oil and Its Constituent Phytochemicals against Rhizopus oryzae: Interaction with Ergosterol. Molecules. 17(12):14418–14433.
   PubMed Web of Science ®Google Scholar
• Nobrega RO, Teixeira APC, Oliveira WA, Lima EO, Lima IO. 2016. Investigation of the antifungal activity of carvacrol against strains of Cryptococcus neoformans. Pharm Biol. 54(11):2591–2596.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Dismukes WE, Dromer F, et al. 2010. Clinical practice guidelines for the management of cryptococcal disease: Update by the Infectious Diseases Society of America. Clin Infect Dis. 50(3):291–322.
   PubMed Web of Science ®Google Scholar
• Sánchez JGB, Martínez-Morales JR, Stashenko E. 2009. Antimycobacterial activity of terpenes. Revista de la Universidad Industrial de Santander. Salud 41(3):231–235.
   Google Scholar